TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER
申请人:Merck Patent GmbH
公开号:EP2964649B1
公开(公告)日:2017-05-10
US9855268B2
申请人:——
公开号:US9855268B2
公开(公告)日:2018-01-02
Triazolo[4,5-d]pyrimidine derivatives
申请人:MERCK PATENT GMBH
公开号:US20160015712A1
公开(公告)日:2016-01-21
Compounds of the formula I
in which R
1
and R
2
have the meanings indicated in Claim
1
, are inhibitors of GCN2, and can be employed, inter alia, for the treatment of cancer.